Parkinson's disease.

1-Methyl-4-phenylpyridinium/adverse effects Adrenal Glands/transplantation Adult Antiparkinson Agents/adverse effects,therapeutic use Brain Chemistry Child Child, Preschool Cytoplasmic Granules/pathology Dyskinesia, Drug-Induced/etiology Environmental Pollutants/adverse effects Fetus Humans Levodopa/adverse effects,therapeutic use Middle Aged Palliative Care Parkinson Disease/diagnosis,drug therapy,epidemiology,etiology Prevalence Research Selegiline/therapeutic use Substantia Nigra/drug effects,pathology,transplantation Time Factors

Antiparkinson Agents Environmental Pollutants Selegiline Levodopa 1-Methyl-4-phenylpyridinium